Pinaverium and Herbs for Irritable Bowel Syndrome Treatment: an Onset and Offset Study (PHIBEST)

• Status: Unknown status
• Trial end date: 2017-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to test the onset of action, offset of action, efficacy, and safety of pinaverium and an herbal medication for irritable bowel syndrome (IBS) for a long term (over one year). Pinaverium has been in many countries, but there is no randomized, double-blind, large sample size, and placebo-controlled study on this medication yet. Tong Xie Yao Fang (Formula for pain and diarrhea) is a historically and contemporarily used traditional Chinese medicine that can be used for IBS. The hypothesis is that the two remedies are effective and safe for IBS treatment with no significant different onset and offset of actions when tested by modern clinical standards and criteria.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Macrohard Institute of Health
• Treatments: Pinaverium

Criteria

Inclusion Criteria:

• 18 to 70 years old age group, male and female

• In accordance with the above Western medicine Rome III standards.

• In accordance with the above description of Deficient Spleen Qi and Liver Qi Stagnation

• Informed consent for treatment

• No change in appetite during treatments periods

Exclusion Criteria:

• Pregnant or lactation female patients, and Fertility male patients

• Present digestive system disease within current three months

• Take IBS medicines within ten days prior to treatment or during treatment

• Take depression medicine within ten days prior to treatment or during treatment

• Take pain reliever medicine within ten days prior to treatment or during treatment

• Have serious primary heart, liver, kidney, lung and blood system diseases, asthma, and Lung and liver dysfunction patients

• If an emergency occurs; a physician terminates the treatment

• Cannot comply with the rules and cannot cooperate